<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="19552">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02852356</url>
  </required_header>
  <id_info>
    <org_study_id>2016-TiMMI-001</org_study_id>
    <nct_id>NCT02852356</nct_id>
  </id_info>
  <brief_title>Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator</brief_title>
  <acronym>TiMMI</acronym>
  <official_title>Prospective Observational and Validation Study Using Time-lapse Morphometry MIRI Imaging Incubator (TiMMI Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ovation Fertility</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ovation Fertility</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of the MIRI-TL time-lapse
      incubator and CultureCoin dish compared to standard big-box incubators and standard culture
      dishes used for embryo culture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following randomization and standard ovarian stimulation protocols to obtain a sufficient
      number of mature (MII) oocytes, these oocytes will be fertilized by Intra-Cytoplasmic Sperm
      Injection (ICSI). If a patient has been randomized to the study group, all inseminated
      oocytes and subsequently all fertilized diploid (2PN) zygotes will be placed in the
      CultureCoin and then into the MIRI-TL Time-lapse incubator and cultured as per normal
      protocol to the blastocyst stage (Day 5/6 or 7). Top quality blastocyst(s) will be
      transferred and monitored for implantation, pregnancy and ongoing birth. Embryo transfers
      will either occur in a fresh or frozen embryo transfer cycle.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy Success</measure>
    <time_frame>14 days</time_frame>
    <description>Live Birth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation</measure>
    <time_frame>28 days</time_frame>
    <description>Presence of Gestational Sac</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo Development</measure>
    <time_frame>7 days</time_frame>
    <description>Blastocyst Utilisation Rate (number of fertilised embryos which develop to usable blastocysts)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Fertility</condition>
  <arm_group>
    <arm_group_label>Control Incubator</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard Incubator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MIRI-TL Timelapse Incubator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Timelapse incubator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Culture Coin Dish</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Culture Coin dish for embryo culture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control dish</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control Dish for embryo culture</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MIRI-TL Incubator</intervention_name>
    <description>MIRI-TL Timelapse incubator</description>
    <arm_group_label>MIRI-TL Timelapse Incubator</arm_group_label>
    <arm_group_label>Culture Coin Dish</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years of age

          -  Women undergoing in vitro fertilization treatment using their own or frozen oocytes

          -  Fresh or Frozen Embryo Transfer

          -  Fertilization by ICSI

          -  At least 4 diploid (2PN) embryos at fertilization check

          -  Willing to have all inseminated oocytes imaged by Miri

          -  Willing to comply with study protocol and procedures Willing to provide written
             informed consent

        Exclusion Criteria:

          -  Fertilization using surgically removed sperm

          -  History of cancer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew VerMilyea, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ovation Fertility</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthew VerMilyea, PhD</last_name>
    <phone>512-610-7474</phone>
    <email>tex@ovationfertility.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alicia Picou, MS</last_name>
    <phone>512-610-7474</phone>
    <email>apicou@ovationfertility.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ovation Fertility</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew VerMilyea, PhD</last_name>
      <phone>512-610-7474</phone>
      <email>tex@ovationfertility.com</email>
    </contact>
    <contact_backup>
      <last_name>Alicia Picou, MS</last_name>
      <phone>512-610-7474</phone>
      <email>apicou@ovationfertility.com</email>
    </contact_backup>
    <investigator>
      <last_name>Matthew VerMilyea, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 1, 2016</lastchanged_date>
  <firstreceived_date>July 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Non-identified data regarding embryo development and pregnancy outcomes may be shared and discussed through presentations and publications.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
